News
5d
Zacks Investment Research on MSNMorgan Stanley (MS) Is a Trending Stock: Facts to Know Before Betting on ItMorgan Stanley (MS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of ...
Morgan Stanley’s evolving business mix, steady asset growth, and strong capital position drive earnings, offering potential ...
The outlook for earnings is brightening, Morgan Stanley CIO Mike Wilson said. More upward revisions has historically led to ...
Shares of Morgan Stanley MS rallied 1.09% to $130.90 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.94% to 6,033.11 and ...
and if you should buy the stock now while it's below $140. Last year was stellar for Morgan Stanley, capitalizing on a resilient macroeconomic environment and strong performance of capital markets.
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $129.5, a high ...
On Thursday, Morgan Stanley raised its price target on shares of Performance Food Group (NYSE: PFGC) to $93 from the previous $92, while maintaining an Equalweight rating on the stock.With the ...
Precious metals traders at top banks including JPMorgan Chase & Co. and Morgan Stanley posted their best performance in five ...
Analysts are confident about the athleisure company's upcoming results, but less sure about its long-term prospects.
Morgan Stanley has lowered its price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $755 from $958, while maintaining an Overweight rating on the stock.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results